One curious thing about the study was that all the participants lost a little bit less weight, on average, than has been measured with the same medications in other trials
Ancillary analysis We used metformin as a control in the secondary analysis
Paper: Podcast: UCL press release: It is critical that people in this group get wrap-around services too
Led by Jamie Gabel, MS PA-C, our team combines extensive expertise in metabolic medicine with a dedication to excellence and innovation
A study published in Annals of Internal Medicine examined how glucagon-like peptide-1 receptor agonists (GLP-1RAs, also known as GLP-1 drugs), sold under brand names such as Ozempic, affected depression risk compared to two other medications used in diabetes treatment
INCLUDES SUPPLIES $ 150/ mo maintenance kit $980 (6.5 month plan) Billed in 6.5 month increments